Antibacterial use and Streptococcus pneumoniae penicillin resistance: A temporal relationship model

Microbial Drug Resistance

Volumn 12, Issue 3, 2006, Pages 158-163

  Mera, Robertino M ^a,c   Miller, Linda A ^b   White, Anthony ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

^c MAI B2092D ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ARTICLE; BACTERIUM ISOLATE; DATA BASE; DRUG USE; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH SURVEY; HUMAN; ITALY; PENICILLIN RESISTANCE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SPAIN; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; EUROPE; HUMANS; MODELS, BIOLOGICAL; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

STREPTOCOCCUS PNEUMONIAE;

EID: 33751227777     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.158     Document Type: Article

References (24)

1. Albrich, W., D. Monnet, and S. Harbarth. 2004. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 10:514-517.
2. Baquero, F. 1996. Antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J. Antimicrob. Chemother. 38 (Suppl. A):117-132.
3. Baquero, F. 1999. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J. Chemother. 11:35-431
4. Bronzwaer, S.L., O. Cars, U. Buchholz, et al. 2002. A European study on the relationship between antibacterial use and antibacterial resistance. Emerg. Infect. Dis. 8:278-282.
5. Diekema, D., A. Brueggemann, and G. Doern. 2000. Antibacterial drug use and changes in resistance in Streptococcus pneumoniae. Emerg. Infect. Dis. 6:552-556.
6. Garcia-Rey, C., L. Aguilar, F. Baquero, J. Casal, and R. Dal-Re. 2002. Importance of local variations in antibiotic consumption and geographical difference of erythromycin and penicillin resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 40:159-164.
7. Goosens, H., M. Ferech, R. Vander Stichele, M. Elseviers, for the ESAC Project Group. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
8. Mera, R. 2005. Predicting the future Streptococcus pneumoniae resistance landscape. Curr. Opin. Pharmacol. 5(5):459-464.
9. Granizo, J.J., L. Aguilar, J. Casal, et al. 2000. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J. Antimicrob. Chemother. 46:767-773.
10. Koeth, L., C. Good, K. Saunders, and C. Jakielaszek. 2004. Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin. Int. J. Antimicrob. Ag. 24:144-149.
11. Kristinsson, K.G., M.A. Hjalmarsdottir, and T.H. Gudnason. 1998. Continued decline in the incidence of penicillin nonsusceptible pneumococci in Iceland. 38th Interscience Conference on Antibacterial Agents and Chemotherapy. San Diego, CA, September 24-27, Abstract C-22.
12. Kuyvenhoven, M., F. van Balen, and T. Verheij. 2003. Outpatient antibiotic prescriptions from 1992 to 2001 in the Netherlands. J. Antimicrob. Chemother. 52:675-678.
13. Lipsitch, M., and B. Levin. 1997. The population dynamics of antibacterial chemotherapy. Antimicrob. Agents Chemother. 41:363-373.
14. Melander, E., K. Ekdahl, and G. Jonsson, et al. 2000. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr. Infect. Dis. J. 19:1172-1177.
15. Nasrin, D., P. Collington, L. Roberts, E. Wilson, et al. 2002. Effect of b lactam antibiotic use in children on pneumococcal resistance to penicillin: a prospective cohort study. Br. Med. J. 324:1-4.
16. Natsch, S., Y.A. Hekster, R. de Jong, E.R. Heerdink, R.M. Herings, and J.W. van der Meer. 1998. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur. J. Clin. Microbiol. Infect. Dis. 17:20-24.
17. NCCLS. 1997. Methods for dilution antibacterial susceptibility tests for bacteria that grow aerobically. 4th ed, vol 17, no. 2. Approved standard M7-A4. NCCLS, Wayne, PA.
18. NCCLS. 2002. Performance standards for antibacterial susceptibility testing. 12th informational supplement. Approved standard, document M100- S12. NCCLS, Wayne, PA.
19. Negri, M.C., M.I. Morosini, E. Loza, and F. Baquero. 1994. In vitro antibiotic selective concentrations of β-lactams for penicillin resistant Streptococcus pneumoniae populations. Antimicrob. Agents Chemother. 38:122-125.
20. Pankuch, G.A., S.A. Jueneman, T.A. Davies, M.R. Jacobs, and P.C. Applebaum. 1998. In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2914-2918.
21. Pihlajamäki, M., P. Kotilainen, T. Kaurila, et al. and the Finnish Study Group for Antibacterial Resistance. 2001. Macrolide resistant Streptcococcus pneumoniae and use of antibacterial agents. Clin. Infect. Dis. 33:483-488.
22. Steinke D., and P. Davey. 2001. Association between antibiotic resistance and community prescribing: A critical review of bias and confounding in published studies. Clin. Infect. Dis. 33 (Suppl 3):S193-S205
23. Thorburn, C.E., S.J. Knott, and D.I. Edwards. (1998). In vitro activities of oral β-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance. Antimicrob. Agents Chemother. 42:1973-9.
24. WHO collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd, accessed 10/19/04.